China Universal Asset Management »

Keros Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $419k 7.2k 58.07
2024-06-30 $194k 4.2k 45.70
2024-03-31 $458k 6.9k 66.20
2023-12-31 $138k 3.5k 39.76
2023-09-30 $24k 758 31.88
2023-06-30 $16k 388 40.18
2023-03-31 $16k 373 42.70
2022-12-31 $13k 280 48.02
2022-09-30 $9.0k 241 37.34

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Keros Therapeutics

BlackRock
BlackRock
Vanguard Group
Darwin Global Management
T. Rowe Price Associates
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Leucadia National Corporation
TCG Crossover Management
Holocene Advisors
Woodline Partners
Geode Capital Management
Citadel Advisors
Braidwell

View all funds holding Keros Therapeutics